Table 1

Patient characteristics

Characteristic
Total patients treated, n15
Age (years)
 Median52
 Range32–71
Gender, n
 Male1
 Female14
Karnofsky Performance Index, n
 90%–100%4
 80%–90%9
 70%–80%2
No. metastatic sites, n
 16
 25
 ≥34
Metastatic site, n
 Liver or lung8
 Other11
No. prior chemotherapy regimens, n
 00
 12
 28
 >25
Prior trastuzumab, n0